share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K:重大事件
美股SEC公告 ·  05/20 16:12

Moomoo AI 已提取核心訊息

Illumina, Inc., a biotechnology company, held its 2024 annual meeting of stockholders on May 16, 2024. During the meeting, stockholders voted on several key proposals. The first proposal, which was approved, involved the election of Frances Arnold, Caroline Dorsa, Robert Epstein, Scott Gottlieb, Gary Guthart, Stephen MacMillan, Anna Richo, Philip Schiller, Susan Siegel, Jacob Thaysen, and Scott Ullem to the Board of Directors for a one-year term. The second proposal, also approved, ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 29, 2024. The third proposal, which received advisory approval, was regarding the compensation paid to the company's named executive officers. The detailed voting results for each proposal were disclosed, with the majority of votes cast in favor of the proposed actions. The report was signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc., on May 20, 2024.
Illumina, Inc., a biotechnology company, held its 2024 annual meeting of stockholders on May 16, 2024. During the meeting, stockholders voted on several key proposals. The first proposal, which was approved, involved the election of Frances Arnold, Caroline Dorsa, Robert Epstein, Scott Gottlieb, Gary Guthart, Stephen MacMillan, Anna Richo, Philip Schiller, Susan Siegel, Jacob Thaysen, and Scott Ullem to the Board of Directors for a one-year term. The second proposal, also approved, ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 29, 2024. The third proposal, which received advisory approval, was regarding the compensation paid to the company's named executive officers. The detailed voting results for each proposal were disclosed, with the majority of votes cast in favor of the proposed actions. The report was signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc., on May 20, 2024.
生物技術公司Illumina, Inc. 於2024年5月16日舉行了2024年年度股東大會。會議期間,股東對幾項關鍵提案進行了投票。第一項提案獲得批准,涉及弗朗西斯·阿諾德、卡羅琳·多爾薩、羅伯特·愛潑斯坦、斯科特·戈特利布、加里·古塔特、斯蒂芬·麥克米蘭、安娜·裏喬、菲利普·席勒、蘇珊·西格爾、雅各布·塞森和斯科特·烏勒姆當選爲董事會成員,任期一年。第二項提案也獲得批准,批准任命安永會計師事務所爲公司截至2024年12月29日的財政年度的獨立註冊會計師事務所。第三項提案已獲得諮詢批准,涉及向公司指定執行官支付的薪酬。每項提案的詳細投票結果均已披露,多數票贊成擬議的行動。該報告由Illumina, Inc.總法律顧問兼秘書查爾斯·達德斯韋爾於2024年5月20日簽署。
生物技術公司Illumina, Inc. 於2024年5月16日舉行了2024年年度股東大會。會議期間,股東對幾項關鍵提案進行了投票。第一項提案獲得批准,涉及弗朗西斯·阿諾德、卡羅琳·多爾薩、羅伯特·愛潑斯坦、斯科特·戈特利布、加里·古塔特、斯蒂芬·麥克米蘭、安娜·裏喬、菲利普·席勒、蘇珊·西格爾、雅各布·塞森和斯科特·烏勒姆當選爲董事會成員,任期一年。第二項提案也獲得批准,批准任命安永會計師事務所爲公司截至2024年12月29日的財政年度的獨立註冊會計師事務所。第三項提案已獲得諮詢批准,涉及向公司指定執行官支付的薪酬。每項提案的詳細投票結果均已披露,多數票贊成擬議的行動。該報告由Illumina, Inc.總法律顧問兼秘書查爾斯·達德斯韋爾於2024年5月20日簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息